PHASE I PILOT STUDY OF TOTAL-BODY IRRADIATION, ANTI-THYMOCYTE GLOBULIN AND CYCLOPHOSPHAMIDE FOLLOWED BY SYNGENEIC OR AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE SCLEROSIS: